心肌损伤中的性别差异:临床特征,结果和预后影响
Mar Rocamora-Horrach1,2,3, Óscar M Peiró1,2,3, Alfredo Bardají1,2,3
1Department of Cardiology, Joan XXIII University Hospital, 43005 Tarragona, Spain.
Journal of clinical medicine
|February 27, 2026
概括
性别显著影响心肌损伤的呈现和预后. 男性的死亡率更高,而女性面临未来心肌梗塞 (MI) 和心力衰竭 (HF) 的风险增加.
科学领域:
- 心脏病学 心脏病学
- 基于性别的医学是基于性别的.
- 临床结果研究研究的临床结果.
背景情况:
- 心肌损伤是已知的不良结果的预测因素.
- 性别对心肌损伤呈现,管理和预后的影响需要进一步调查.
- 了解性别差异对于优化第三级医院环境中的患者护理至关重要.
研究的目的:
- 检查心肌损伤的呈现,管理和预后中的基于性别的差异.
- 为了比较患有心肌损伤的男性和女性之间的临床特征,管理策略以及短期和长期结果.
- 评估性与肌肉心脏损伤之间的潜在相互作用,以评估长期结果.
主要方法:
- 追溯观察性研究,对3620名接受托罗邦素检测的急诊室患者进行了追溯观察研究 (2012年1月 - 2013年12月).
- 心肌损伤被分类为1型心肌梗塞 (T1MI),2型心肌梗塞或非缺血性心肌损伤 (NIMI).
- 根据性别对临床特征,治疗方法和结果进行比较,平均随访时间为四年;进行了相互作用分析.
主要成果:
- 心肌损伤在男性中更为普遍 (31.4%对25.8%),男性性别独立地与风险增加有关.
- 非缺血性心肌损伤 (NIMI) 在女性中更常见,而1型心肌梗塞 (T1MI) 在男性中占主导地位.
- 妇女的住院率较低,但未来心肌梗塞 (MI) 和心力衰竭 (HF) 的调整风险较高;男性的长期死亡率调整较高.
结论:
- 在心肌损伤类型和预后方面存在显著的性别差异.
- 患有心肌损伤的妇女在随后发生心肌梗塞和高血压的风险较高.
- 患有心肌损伤的男性具有更高的长期死亡风险,性别和心肌损伤在整体结果之间没有显著的相互作用.
相关概念视频
Myocarditis II: Clinical Features and Diagnostic Tests
385
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
385
Myocarditis I: Introduction
493
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
493
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
535
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
535
Acute Coronary Syndrome III: Diagnostic Studies
338
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
998
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
998
Coronary Artery Disease III: Clinical Manifestations
479
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
479


